Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
This is a purely retrospective and observational monocentric study
Marginal Zone B Cell Lymphoma
clinical characteristics of Marginal zone lymphoma patients, to descrive clinical characteristics of Marginal zone lymphoma patients who were diagnosed and treated in our Hospital., through study completion, an average of 1 years
effectiveness, It includes:

1. Description of treatment duration and causes of treatment discontinuation.
2. Description of adverse events / safety of the treatments
3. Assessment of patients' survival.
4. Description of the medical resource utilization, including number of emergency department visits, hospitalizations, use of hematopoietic growth factors and antibiotics, and blood product transfusions.
5. Patient clinical and biological characteristics and disease biological profile at baseline of Marginal zone lymphoma cases, through study completion, an average of 1 years|safety, It includes:

1. Description of treatment duration and causes of treatment discontinuation.
2. Description of adverse events / safety of the treatments
3. Assessment of patients' survival.
4. Description of the medical resource utilization, including number of emergency department visits, hospitalizations, use of hematopoietic growth factors and antibiotics, and blood product transfusions.
5. Patient clinical and biological characteristics and disease biological profile at baseline of Marginal zone lymphoma cases, through study completion, an average of 1 years
the study aimed at describing the characteristics and outcome of Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018